These results suggest that elevated ZNF800 expression may promote LGG cell cycle progression (especially S-phase) and proliferative capacity through the up-regulation of CyclinD1, CyclinE1, CDK2, and CDK4, thereby promoting malignant tumor progression. Here, CDK2 is linked to cancer.